Rodeo Therapeutics competitors

Rodeo Therapeutics's competitors include Cantabio Pharmaceuticals, Cyclacel Pharmaceuticals, Minerva Neurosciences and XOMA
Add company...
Rodeo Therapeutics
Rodeo Therapeutics is a preclinical-stage biotech company.
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other serious diseases.
Minerva Neurosciences
Minerva Neurosciences is a clinical-stage biopharmaceutical company.
XOMA
XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.
Founding Date
Founding Date
N/A
Founding Date
2009
Founding Date
1992
Founding Date
2007
Founding Date
1981
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Sunnyvale, US HQ
Locations
Berkeley Heights, US HQ
Dundee City, GB
Locations
Waltham, US HQ
Locations
Emeryville, US HQ
Employees
Employees
N/A
Employees
11
Employees
1319% decrease
Employees
11
Employees
1878% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.1 m
Valuation ($)
19.4 m
Valuation ($)
337.3 m
Valuation ($)
146 m
Twitter followers
Twitter followers
N/A
Twitter followers
803
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
185

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$843k (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$52.7m (FY, 2017)
Net income
Net income
N/A
Net income
($2m) (FY, 2018)
Net income
($11.8m) (FY, 2016)
Net income
($31.5m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 5.9m
Total funding raised
N/A
Total funding raised
$ 152.2m
Total funding raised
$ 51.2m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Cantabio Pharmaceuticals
HQ
Sunnyvale, US
Employees
11

Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.

View company
Cyclacel Pharmaceuticals
HQ
Berkeley Heights, US
Employees
13↓ 19% decrease

Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other serious diseases.

View company
Minerva Neurosciences
HQ
Waltham, US
Employees
11

Minerva Neurosciences is a clinical-stage biopharmaceutical company.

View company
XOMA
HQ
Emeryville, US
Employees
18

XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.

View company